Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UK
Tendering Procedures: Generally only one firm has been invited to bid
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
VARIOUS PHARMACEUTICALS SUPPLIERS
VARIOUS
VARIOUS Ontario
Canada
A1A1A1
Nature of Requirements:
1. Definition of the requirement
PSPC proposes to establish contract pricing with manufacturers of patent protected pharmaceuticals on behalf of the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Drugs and Vaccines on an as-and-when requested basis.
2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements)
Any interested supplier must demonstrate by way of a statement of capabilities that its pharmaceutical product meets the following requirements:
a) Must have a valid DIN number;
b) Must have the same active pharmaceutical ingredient (API) and strength as indicated in the list below.
c) Must be able to deliver on a national scale.
3. Applicability of the trade agreement(s) to the Canadian Free Trade Agreement (CFTA), the Canada - Korea Free Trade Agreement, the Canada - Chile Free Trade Agreement (CCFTA), the Canada - Colombia Free Trade Agreement, the Canada - Honduras Free Trade Agreement, the Canada - Panama Free Trade Agreement, the Canada - Peru Free Trade Agreement (CPFTA), the Canada - Ukraine Free Trade Agreement (CUFTA), the Canada - European Union Comprehensive Economic and Trade Agreement (CETA), the Canada - United Kingdom Trade Continuity Agreement (Canada-UK TCA), the Revised World Trade Organization Agreement on Government Procurement (WTO-AGP), and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP),
4. Justification for the Pre-Identified Supplier
This requirement is being negotiated with the following suppliers as they are the only known suppliers capable of providing the drugs listed at the bottom of this document. The suppliers are:
AA Pharma Inc., AbbVie Canada, ASM Canada, Astra Zeneca Canada, Bayer Canada, BGP Pharma ULC, Covis Pharma Canada Ltd., Eli Lilly Canada, Fresenius-Kabi Canada, GSK Consumer Health, Hikma Canada Ltd., Johnson & Johnson Canada, Leo Pharma Canada, Lundbeck Canada Inc., Lupin Pharma Canada, Mallinckrodt Canada Inc., Merck Canada, Novartis Pharmaceuticals Canada Inc., Novo Nordisk Canada Inc., Organon Canada Inc., Otsuka Canada Pharma, Pfizer Canada, Roche Canada, Sanofi-Aventis Canada Inc., SteriMax Inc., Takeda Canada Inc., Viiv Healthcare Canada.
5. Government Contracts Regulations Exception(s)
The following exception(s) to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) as only one supplier is capable of performing the work.
6. Period of the proposed contract or delivery date
From August 1, 2022 to June 30, 2023, with an option to extend the contract period for two additional one-year periods from July 1, 2023 to June 30, 2024 and July 1, 2024 to June 30, 2025.
7. Closing date for a submission of a statement of capabilities
The closing date and time for accepting statements of capabilities is June 16, 2022 at 2:00 p.m.
8. Inquiries and statements of capabilities are to be directed to:
Julia Summers
Telephone: (613) 298-2724
E-mail: j••••••••@••••••••.••.ca
LIST OF ITEMS
ABILIFY MAINTENA VL 300MG
ABILIFY MAINTENA VL 400MG
ACETYLCYST VL 200MG/ML 10X30ML
ADVAIR DISKUS 100MCG 60DS
ADVAIR DISKUS 250MCG 60DS
ADVAIR DISKUS 500MCG 60DS
ADVAIR MDI INHALER 125MCG 120DS
ADVAIR MDI INHALER 250MCG 120DS
AERIUS ALRGY TB 5MG BX 20
AERIUS ALRGY TB 5MG BX 30
ANDROGEL PUMP 1% 2x60 DS
ANDROGEL SACHET 1% 30x2.5G
ANDROGEL SACHET 1% 30x5G
ASMANEX TWISTHALER 200MCG 60
ASMANEX TWISTHALER 400MCG 60
ATROPINE SY0.1MG/ML 10X10ML
AVENTYL CAPS 10MG 100
AVENTYL CAPS 25MG 100
BASAGLAR KPEN 100U/ML 5X3ML
BENADRYL LIQ CHLD B/GUM 100mL
BICILLIN L A SYR 10X2ML
BOTOX VL 100U 1
BREO ELLIPTA INH 100MCG 30DS
BREO ELLIPTA INH 200MCG 30DS
BRILINTA TB 90MG HOP 60
CALC CHLOR ANSYR 10% 10X10ML
CALCIUM CHLORIDE SYR 10% L 10X10ML
CALC GLUC 100MG/ML 25X10ML
CANESTEN COMBIPACK TRMT 3DAY
CEFTIN SUSP 125MG/5ML 100ML
CIPRODEX OTIC SUSP 7.5ML
CLAVULIN 400 SUSP 70ML
CLOPIXOL DEP 200MG/ML 10X1ML
COMBANTRIN TB 125MG 12
COSENTYX AI SSR 150MG 2X1ML
DALACIN C PALMITATE 100ML
DEPO PROVERA CONT INJ SYR 150MG/ML 1ML 9737611 US
DEPO PROVERA SUSP 150MG/ML 1ML
DEXILANT CP DR 30MG 90
DEXILANT CP DR 60MG 90
DIPROSALIC OINT 50G
DOVATO TB 50MG/300MG 30
DOVOBET GEL 0.5MG/50MCG 80G
DOVOBET OINT 0.5MG/50MCG 120G
ENSTILAR 50MCG/0.5MG 60G
EPINEP SYR.1MG 1 1/2L10X10ML
FLOVENT DISK PD 250MCG
FLOVENT HFA 125MCG/DS 120DS
FLOVENT HFA 250MCG/DS 120DS
FLUANXOL DEPOT100MG/ML10X1ML
FORXIGA TB 10MG BLST 3X10
FORXIGA TB 5MG BLST 3X10
FOMEPIZOLE FOR INJ 2X1.5ML
GLUCAGON RDNA SYR 1MG 1X1ML
HUMALOG CARTRIDGE 100U/ML 5X3ML
HUMALOG KW 100U/ML 5X3ML
HUMIRA PN 40MG/0.8ML 2X0.8ML
HUMIRA PREFILLED SYR 40MG/0.8ML
HUMULIN N CART 100U/ML 5X3ML
HUMULIN N VL 100U/ML 10ML
HUMULIN R CART 100U/ML 5X3ML
IMITREX NAS SP 20MG 1X2
INTUNIV XR TB 1MG 100
INTUNIV XR TB 2MG 100
INTUNIV XR TB 3MG 100
INTUNIV XR TB 4MG 100
ISENTRESS TB 400MG 60
JANUMET TB 50MG/1000MG 60
JANUVIA TB 100MG 100
JANUVIA TB 50MG 30
JULUCA TB 50MG/25MG 30
KADIAN CAPS 20MG 100
KADIAN CAPS 50MG 100
KADIAN CAPS 100MG 50
KADIAN CAPS 10MG 100
KALETRA TB 200-50MG 120
KWELLADA-P 5% PERM LOT 100ML
LAMISIL CR 1% 30G
LANTUS CART 100IU/ML 5X3ML
LANTUS SOLOSTAR 5X3ML
LEVEMIR PENFIL100U/ML 5X3ML
LOVENOX PROT NDL 100MG10X1ML
LOVENOX SYR 40MG/0.4ML
LOVENOX VL 100MG/ML
LUPRON DEPOT INJ KIT 3.75MG
LUPRON DEPOT INJ KIT 11.25MG
LUPRON DEPOT INJ KIT 22.5MG1
LUPRON DEPOT INJ KIT 7.5MG 1
MAVIRET TB 100/40MG BLST 84
METHADOSE N/DYE S/F UNFLV 1L
METHOPRAZINE TB 25MG 100
MEZAVANT TB ER 1.2G 120
MIRENA IUS 1
NIX CR DERMAL 5% 30G
NIX CR RIN LICE 1% 59ML
NORVIR TB 100MG 30
NOVOLIN GE NPH CART 5X3ML
NOVORAPID CART100U/ML 5X3ML
NUVARING VAG RING
OCREVUS INJ VL 30MG/ML 10ML
OZEMPIC 4MG/PEN PRE FILLED 1MG/DOSE 3ML
OZEMPIC PRE FLD 1X2MG1.5ML
PEN VK TB 300MG 100
PEN VK TB 300MG 1000
PROTOPIC OINT 0.03% 60G
PROTOPIC OINT 0.10% 60G
PULMICORT NEB 0.25MG 20X2ML
PULMICORT NEB 0.5MG 20X2ML
R&C SHP&CND W/NIT COMB 50ML
REACTINE RG TB 5MG
RESTORALAX SACHET 17G
REXULTI TB 0.5MG 30
REXULTI TB 1MG 30
ROBAXIN TB 500MG 50
SATIVEX SP 3X10ML
SAXENDA 6MG/ML PNPREFIL5X3ML
SEEBRI BREEZHALER 50MCG BLST 1 DEVICE 3X10
SINEQUAN CAPS 100MG 100
SINEQUAN CAPS 50MG 100
SINEQUAN CAPS 75MG 100
SULFATRIM DS TB 800-160MG500
SYMBICORT TURBU 100MCG 120DS
SYMBICORT TURBU 200MCG 120DS
SYNTHROID TB 100MCG 90
SYNTHROID TB 112MCG 90
SYNTHROID TB 125MCG 90
SYNTHROID TB 137MCG 90
SYNTHROID TB 150MCG 90
SYNTHROID TB 175MCG 90
SYNTHROID TB 200MCG 90
SYNTHROID TB 25MCG 90
SYNTHROID TB 50MCG 90
SYNTHROID TB 75MCG 90
SYNTHROID TB 88MCG 90
TASIGNA CAPS 200MGBL 4X(7X4)
TIVICAY TB 50MG 30
TNKASE VL 50MG 1X50MG
TOUJEO SOLOSTAR PREFILLED PEN 300UNIT/ML 5
TOVIAZ TB 8MG 30
TRESIBA FLEXTO 100U/ML 5X3ML
TRESIBA FLEXTO 200U/ML 3X3ML
TRINTELLIX TB 10MG 28
TRINTELLIX TB 20MG 28
TRINTELLIX TB 5MG 28
TRIUMEQ TB 600/50/300MG UD30
TYLENOL CHILD BANANA STRAWBERRY 100ML
TYLENOL CHILD DYE FREE BERRY 100ML
TYLENOL SUSP CHILD BUBBLE GUM 100ML
TYLENOL SUSP DYE FREE CHERRY 100ML
TYLENOL SUSP GRAPE 160MG/5ML 100ML
TYLENOL SUSP LIQ CHILD BERRY 2X100ML
TYLENOL SUSP160MG/5MLGP100ML
ULTIBRO BREEZHALER .11/.05MG 3X10
VICTOZA PRE FILLED 3X3.0ML
VOLTAREN EMUL BACK/MUSC 30G
VOLTAREN EMUL BACK/MUSC 50G
VOLTAREN EMUL BACK/MUSC 100G
VOLTAREN EMULGEL 12H EXTRA STRENGTH 30G
VOLTAREN EMULGEL EXTRA STRENGTH 100G
VOLTAREN EMULGEL JOINT PAIN 120G
VOLTAREN EMULGEL X-STR JOINT PAIN 100G
VYVANSE CAPS 10MG 100
VYVANSE CAPS 20MG 100
VYVANSE CAPS 30MG 100
VYVANSE CAPS 40MG 100
VYVANSE CAPS 50MG 100
VYVANSE CAPS 60MG 100
VYVANSE CAPS 70MG 100
XARELTO TB 10MG 50
XARELTO TB 15MG 1X90
XARELTO TB 20MG 90
XELJANZ TB 5MG 60
XOLAIR PFS SYR 150MG/ML 1
YASMIN TB 21
YASMIN TB 28
ZAXINE TB 550MG 60
Delivery Date: 01/08/2022
You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.
Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
